Wistar scientists develop novel immunotherapy technology for prostate cancer – EurekAlert (press release)
|
Wistar scientists develop novel immunotherapy technology for prostate cancer
EurekAlert (press release) "This is an important demonstration of the possibilities opened up for immunotherapy by DMAb technology to direct in vivo production of antibodies of major relevance to human cancer," said David B. Weiner, Ph.D., executive vice president of The Wistar … |
